However, we did not find  the presence of gut microbiota in patients with advanced EGFR + NSCLC that have been associated with effective immunotherapy in EGFR- NSCLC patients, such as Akkermansia muciniphila, Bifidobacterium bifidum, or Bifidobacterium breve. This evidence concerns the gene EGFR and non-small cell lung carcinoma.